Exclusive Content
Lung cancer patients in England will be first in Europe to receive Amgen’s ‘revolutionary’ drug
Lung cancer patients in England will become the first in Europe to receive a drug made by a US biotech company that targets a specific gene mutation.
NHS England will be fast-tracking Amgen's lung cancer drug sotorasib after it was shown in clinical trials to...
Give community pharmacists greater role in delivering flu jabs: think tank urges government
A think tank on the impact of longevity on society has urged the government to allow community pharmacists a greater role in delivering flu...
MHRA approves Covid-19 boosters but final decision on programme still pending
Medicines and Healthcare products Regulatory Agency today (September 9) gave the go-ahead for Pfizer and AstraZeneca's Covid-19 vaccine to be used as booster shots,...
EU lists rare nerve disorder as possible side-effect of AstraZeneca Covid-19 vaccine
Europe's medicines regulator has added a rare nerve-damaging disorder, Guillain-Barré syndrome, as a possible side-effect of AstraZeneca's Covid-19 vaccine, regular safety updates from the watchdog showed on Wednesday.
The European Medicines Agency also tagged some...
More at risk of type 2 diabetes after gaining weight during lockdown: NHS study
People having put weight during the lockdowns are at higher risk of developing type 2 diabetes and those seeking weight-loss help has also seen...
UK sets aside extra £5.4bn to help Covid-hit NHS
Government will set aside a further £5.4 billion over the next six months to help the NHS cover additional costs from the coronavirus pandemic...